MedPath

Examination to identify the relationship between temperature/soaking time of the Ivermectin whole body method and transition to horny layer

Not Applicable
Conditions
scabies
Registration Number
JPRN-UMIN000011016
Lead Sponsor
Tokyo University of Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1) The patient who has an obstacle in the barrier of the skin according to a skin disorder 2) Those who have the following diseases in the past or the present - Liver disease - The disease considered to affect a test result by a doctor in attendance in addition to this, or the disease considered that medication of ivermectin brings about a disadvantage 3) The superfluous ingestion person of the coffee containing caffeine, or a drink (>8 cup / day) 4) The abuse person of medicine or alcohol 5) The addict of an illegal drug 6) The woman who offered the blood of 400mL within the man and woman who offered the blood of 200mL within four weeks before the examination or the man who offered the blood of 400mL within 12 weeks, and 16 weeks 7) Those who participated in four weeks to the clinical test using other investigational new drugs before this start of test 8) Those who have an anamnesis of hypersensitivity in the ingredient of a Stromectol® Tablets or the charge of baby purification (Pigeon, Inc.) 9) The woman, the child below 15 km who have become pregnant 10) Those whom the examination doctor in attendance judged to be unsuitable as a subject 11) Those who have used medication within a week

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effects of difference in temperature/ soaking time/ bath agent on the concentration of Ivermectin transited to horny layer
Secondary Outcome Measures
NameTimeMethod
Identification of adverse events by examined drug
© Copyright 2025. All Rights Reserved by MedPath